Biovitrum creates largest CRO in the Nordic region

By Wai Lang Chu

- Last updated on GMT

Related tags: Pharmacology

Biopharma company Biovitrum has purchased iNovacia making it the
Nordic region's largest contract-research organization (CRO) in
early drug discovery.

Outsourcing in the Nordic region, particularly in the drug discovery sector has not been without its difficulties. Traditionally the Nordic high-salary environment has taken a backseat to Asia and its primarily low-cost area.

For Biovitrum, the formation and spin-off of existing company, iNovacia offers an opportunity to secure regional access to key technical expertise for early drug discovery projects.

"As an independent company, iNovacia will have the possibility to further develop within the CRO sector,"​ said Biovitrum's CEO Mats Petterson.

"Biovitrum, as a customer, can continue to efficiently operate early-stage pharmaceutical projects of high quality."

The market for contract research in the pharmaceutical industry is undergoing strong growth internationally and opinion is divided on which country will represent the next big market in outsourcing.

As well as the Nordic countries, the Netherlands, with its huge pension fund industry is frequently mentioned and is even a topic of conversation in ultra-conservative and protective Switzerland.

As evidence of the burgeoning Nordic market, >iNovacia​ has secured assignments from partners outside the Nordic region, entering into alliance with Asinex, a company within the pharmaceutical chemicals sector.

With principal operations in Moscow, Asinex will hold approximately 20 per cent of the shares of iNovacia.

Through the alliance with Asinex, iNovacia gains access to a chemical library of top international ranking and a competent partner for the development of new chemicals.

Related news

Show more

Related products

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q² Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Related suppliers

Follow us


View more